Pro Pharmaceuticals Group Expands Sustainable Logistics Through DHL GoGreen Plus

Pro Pharmaceuticals Group has incorporated DHL Express GoGreen Plus into its international logistics operations, as part of its ongoing approach to responsible and sustainable pharmaceutical supply. The programme applies to eligible international shipments moved through DHL Express and forms part of a broader focus on improving the environmental profile of the company's global logistics activity.

GoGreen Plus supports reductions in greenhouse gas emissions associated with air transport through DHL's use of Sustainable Aviation Fuel (SAF) and its book-and-claim insetting model for eligible DHL Express shipments. For Pro Pharmaceuticals Group, international transport is an essential part of helping hospitals, pharmaceutical companies and clinical trial organisations access medicines across Australia, Europe and other global markets.

As these activities continue to grow, ProPG is increasingly focused on improving not only the efficiency and reliability of its pharmaceutical supply chain, but also its environmental impact. The adoption of GoGreen Plus forms part of this broader approach.

Making International Pharmaceutical Logistics More Sustainable

International air freight remains a core part of how medicines reach Australian hospitals, pharmacies and clinical trial sites. Pharmaceutical products are frequently sourced from overseas markets when they are affected by medicine shortages, unavailable through routine Australian supply channels, or required urgently to support patient treatment.

Comparator and reference-listed drug (RLD) supplies for clinical trials often need to move between multiple countries within defined timeframes, and many medicines require temperature-controlled, GDP-aligned transport to preserve their stability and efficacy.

These operational requirements mean international transport cannot simply be scaled back or slowed down without risking patient access. What can be improved is the environmental footprint of the transport used to move these products. Because a meaningful share of

ProPG's international logistics activity relies on air freight, addressing the environmental profile of that transport is a practical way to work toward a more sustainable pharmaceutical supply chain, without compromising the reliability that medicine access depends on.

How DHL GoGreen Plus Works

DHL Express GoGreen Plus is a service that allows shipping customers to support the use of Sustainable Aviation Fuel within DHL's global air transport network. SAF is produced from renewable feedstocks and is associated with a lower lifecycle carbon footprint than conventional jet fuel.

Rather than requiring each individual parcel to physically travel on a SAF-fuelled aircraft, which is not how global air freight networks operate, GoGreen Plus uses a book-and-claim insetting model. Under this approach, DHL purchases SAF and introduces it into its fuel supply chain at the point of production or refuelling, then allocates the associated emissions-reduction benefit to customers who opt into the programme. In practical terms, this means Pro Pharmaceuticals Group's participation in GoGreen Plus supports the volume of SAF used within DHL's network and contributes to emissions reductions across that network, in proportion to the shipments enrolled, rather than guaranteeing that any specific shipment travelled on a SAF-fuelled aircraft.

Further detail on how the programme works is available directly from DHL Express GoGreen Plus.

Sustainability Within a Reliable Pharmaceutical Supply Chain

For Pro Pharmaceuticals Group, environmental improvements are pursued within, not instead of, the operational requirements of pharmaceutical supply. GDP-aligned handling, validated transport conditions, temperature control where required, and consistent delivery timeframes remain the priority for every shipment, whether it involves unlicensed medicine supply, shortage medicines, or comparator products for clinical trials.

Alongside GoGreen Plus, ProPG continues to focus on efficient sourcing, consolidated shipments and more efficient transport planning as ways to reduce unnecessary freight movements. These measures are assessed for their effect on delivery timeframes and compliance before they are adopted, so that environmental improvements do not come at the expense of product quality, delivery urgency or patient access.

“Pharmaceutical supply chains cannot simply stop moving products internationally, particularly when medicines are required urgently or during shortages. Our responsibility is therefore to look for practical ways to make those supply chains more efficient and more sustainable wherever possible,” said Sandip Manku, Founder and Managing Director of Pro Pharmaceuticals Group.

Supporting Australia–Europe Pharmaceutical Supply

Pro Pharmaceuticals Group operates licensed pharmaceutical sites across Australia and Europe, supporting international sourcing relationships that connect hospitals, pharmaceutical companies and clinical trial organisations with medicines that can be difficult to access through domestic channels alone. Shipments moving between these markets frequently rely on DHL Express for time-critical delivery, making GoGreen Plus a relevant addition to this part of ProPG's operations.

The initiative complements ProPG's wider international sourcing and distribution activity rather than replacing it, and is applied to eligible shipments as part of standard freight arrangements with DHL.

Our Approach to Responsible Logistics

Pro Pharmaceuticals Group uses DHL Express GoGreen Plus on eligible international shipments, supporting emissions reductions within DHL's air transport network through Sustainable Aviation Fuel and the GoGreen Plus book-and-claim model.

Pro Pharmaceuticals Group continues to develop international pharmaceutical sourcing and logistics capabilities supporting hospitals, pharmaceutical companies and clinical-trial organisations across Australia and international markets. Organisations wishing to discuss international pharmaceutical sourcing, medicine shortages or clinical-trial supply can contact Pro Pharmaceuticals Group.